Amyloidogenic hexapeptide fragment of medin: Homology to functional islet amyloid polypeptide fragments

Amyloid

Volumn 11, Issue 2, 2004, Pages 81-89

  Reches, Meital ^a   Gazit, Ehud ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amyloid formation; Aortic medial amyloid; Protein misfolding; Self assembly; Stacking interactions

Indexed keywords

ALANINE; AMYLIN; ASPARAGINYLPHENYLALANYLGLYCYLALANYLISOLEUCYLLEUCINE; ASPARAGINYLPHENYLALANYLGLYCYLSERYLVALINE; ASPARAGINYLPHENYLALANYLGLYCYLSERYLVALYLGLUTAMINE; ASPARAGINYLPHENYLALANYLLEUCYLVALYLHISTIDINE; HEXAPEPTIDE; ISOLEUCINE; MEDIN; PENTAPEPTIDE; PHENYLALANINE; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; CONFERENCE PAPER; GEL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN INTERACTION; SEQUENCE HOMOLOGY;

AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMYLOID; AMYLOIDOSIS; ANTIGENS, SURFACE; GLYCOPROTEINS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MILK PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 4544301224     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120412331272287     Document Type: Conference Paper

References (30)

1. Harper JD and Lansbury PT Jr. (1997). Models of amyloid seeding in Alzheimer disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66, 385-407.
2. Sunde M and Blake CCF (1998). From the globular to the fibrous state. Protein structure and structural conversion in amyloid formation. Quart Rev Biophys 31, 1-3.
3. Dobson CM (1999). Protein misfolding, evolution and disease. Trends Biochem Sci 24, 329-332.
4. Sipe JD and Cohen AS (2000). Review: History of the amyloid fibril. J Struct Biol 130, 88-98.
5. Rochet JC and Lansbury PT Jr. (2000). Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10, 60-68.
6. Gazit E (2002). The "correctly-folded" state of proteins: Is it a metastable state? Angew Chem Int Ed 41, 257-259.
7. Jarrett JT and Lansbury PT Jr. (1993). Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
8. Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H and Kapurniotu A (2000). Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 295, 1055-1071.
9. Westermark P, Engström U, Johnson KH, Westermark GT and Betsholtz C (1990). Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid - fibril formation. Proc Natl Acad Sci USA 87, 5036-5040.
10. Kayed R, Bernhagen J, Greenfield N, Sweimeh K, Brunner H, Voelter W and Kapurniotu A (1999). Conformational transitions of Islet amyloid polypeptide (LAPP) in amyloid formation in vitro. J Mol Biol 287, 781-796.
11. Höppener JWM, Ahrén B and Lips CJM (2000). Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343, 411-419.
12. Azriel R and Gazit E (2001). Analysis of the structural and functional elements of the minimal active fragment of Islet Amyloid Polypeptide (IAPP): An experimental support for the key role for the phenylalanine residue in amyloid formation. J Biol Chem 276, 34156-34161.
13. Mazor Y, Gilead S, Benhar I and Gazit E (2002). Identification and characterization of a novel molecular-recognition and self-assembly domain in the islet amyloid polypeptide. J Mol Biol 322, 1013-1024.
14. Gazit E (2002). A possible role for π-stacking in the self-assembly of amyloid fibrils. FASEB J 16, 77-83.
15. Gazit E (2002). Global analysis of tandem aromatic octapeptide repeats: the significance of aromatic-glycine motif. Bioinformatics 18, 880-883.
16. Reches M, Porat Y and Gazit E (2002). Amyloid fibrils formation by penta-and tetrapeptide fragments of human calcitonin. J Biol Chem 277, 35475-35480.
17. Reches M and Gazit E (2003). Casting metal nanowires within discrete self-assembled peptide nanotubes. Science 300, 625-627.
18. Häggqvist B, Näslund J, Sletten K, Westermark GT, Mucchiano G, Tjernberg LO, Nordstedt C, Engström U and Westermark P (1999). Medin: an-integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci U S A 96, 8669-8674.
19. Mucchiano G, Cornwell GG III and Westermark P (1992). Senile aortic amyloid. Evidence for two distinct forms of localized deposits. Am J Pathol 140, 811-877.
20. Lyon RP and Atkins WM (2001). Self-assembly and gelation of oxidized glutathione in organic solvents. J Am Chem Soc 123, 4408-4413.
21. Tjernberg L, Hosia W, Bark N, Thyberg J and Johansson J (2002). Charge attraction and β propensity are necessary for amyloid fibril formation from tetrapeptides. J Biol Chem 277, 43243-43246.
22. Khurana R, Uversky VN, Nielsen L and Fink AL (2001). Is Congo red an amyloid-specific dye? J Biol Chem 276, 22715-22721.
23. Lansbury PT Jr, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RGS, Tidor B and Griffin RG (1995). Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nature Struct Biol 2, 990-998.
24. Lazo ND and Downing DT (1998). Amyloid fibrils may be assembled from beta-helical protofibrils. Biochemistry 37, 1731-1735.
25. Lazo ND and Downing DT (1999). Fibril formation by amyloid-beta proteins may involve beta-helical protofibrils. J Peptide Res 53, 633-640.
26. Jenkins J and Pickersgill R (2001). The architecture of parallel beta-helices and related folds. Prog Biophys Mol Biol 77, 111-175.
27. Salomon AR, Marcinowski KJ, Friedland RP and Zagorski MG (1996). Nicotine inhibits amyloid formation by the β-peptide. Biochemistry 35, 13568-13578.
28. Thomas T, Nadackal TG and Thomas K (2001). Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation. Neuroreport 12, 3263-3267.
29. Forloni G, Colombo L, Girola L, Tagliavini F and Salmona M (2001). Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett 487, 404-407.
30. Corderio Y, Gomes MPB and Silva JL (2004). Modulation of prion protein oligomerization, aggregation, and β-sheet conversion by 4,4′-dianilino-1,1′-binaphthyl-5,5′-sulfonate (bis-ANS). J Biol Chem 279, 5346-5352.